• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not.

作者信息

Honore Patrick M, Redant Sebastien, De Bels David

机构信息

ICU Department, Centre Hospitalier Universitaire Brugmann, Place Van Gehuchtenplein,4, 1020, Brussels, Belgium.

出版信息

Crit Care. 2020 Sep 11;24(1):553. doi: 10.1186/s13054-020-03277-8.

DOI:10.1186/s13054-020-03277-8
PMID:32917263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7483498/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/7488508/876b675f0de3/13054_2020_3277_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/7488508/876b675f0de3/13054_2020_3277_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06de/7488508/876b675f0de3/13054_2020_3277_Fig1_HTML.jpg

相似文献

1
Reliability of biomarkers of sepsis during extracorporeal therapies: the clinician needs to know what is eliminated and what is not.体外治疗期间脓毒症生物标志物的可靠性：临床医生需要了解哪些被清除了，哪些没有。
Crit Care. 2020 Sep 11;24(1):553. doi: 10.1186/s13054-020-03277-8.
2
Endocan measurement for the postmortem diagnosis of sepsis.内皮糖蛋白检测用于脓毒症的尸检诊断
Leg Med (Tokyo). 2014 Jan;16(1):1-7. doi: 10.1016/j.legalmed.2013.09.007. Epub 2013 Oct 8.
3
Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin.几种生物标志物在脓毒症患者管理中的作用：C 反应蛋白、降钙素原、前降钙素原和肾上腺髓质中段肽。
Clin Chem Lab Med. 2016 Jan;54(1):163-8. doi: 10.1515/cclm-2015-0243.
4
The use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial.使用中肾上腺髓质原(proadrenomedullin)来识别脓毒症的严重程度和治疗反应 - 一项大型随机对照试验的二次分析。
Crit Care. 2018 Mar 21;22(1):79. doi: 10.1186/s13054-018-2001-5.
5
Biomarkers and clinical scores to identify patient populations at risk of delayed antibiotic administration or intensive care admission.用于识别有延迟使用抗生素或入住重症监护病房风险的患者人群的生物标志物和临床评分。
Crit Care. 2019 Oct 29;23(1):335. doi: 10.1186/s13054-019-2613-4.
6
Assessment of novel biomarkers: sTREM-1, pentraxin-3 and pro-adrenomedullin in the early diagnosis of neonatal early onset sepsis.新型生物标志物：sTREM-1、降钙素原和肾上腺髓质前体在新生儿早发性败血症早期诊断中的评估。
J Neonatal Perinatal Med. 2020;13(1):47-54. doi: 10.3233/NPM-180131.
7
Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin.利钠肽原和肾上腺髓质素原对脓毒症严重程度及预后的预测作用
Chin J Traumatol. 2010 Jun 1;13(3):152-7.
8
[Sepsis biomarkers dynamics as an indicator of intensive care effectiveness].[脓毒症生物标志物动态变化作为重症监护效果的指标]
Khirurgiia (Mosk). 2019(2):53-57. doi: 10.17116/hirurgia201902153.
9
MR- proADM to detect specific types of organ failure in infection.MR-proADM 用于检测感染中的特定类型的器官衰竭。
Eur J Clin Invest. 2020 Jun;50(6):e13246. doi: 10.1111/eci.13246. Epub 2020 May 19.
10
[The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].[促肾上腺髓质素作为脓毒症预后和风险分层新生物标志物的研究]
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2008 Aug;20(8):452-5.

引用本文的文献

1
Hemoperfusion with Seraph-100 in septic patients removes pathogens and improves clinical outcomes.在脓毒症患者中使用Seraph-100进行血液灌流可清除病原体并改善临床结局。
Sci Rep. 2025 May 21;15(1):17626. doi: 10.1038/s41598-025-01280-z.
2
Risk factors for mortality in patients with sepsis on extracorporeal membrane oxygenation and/or continuous renal replacement therapy: a retrospective cohort study based on MIMIC-IV database.接受体外膜肺氧合和/或持续肾脏替代治疗的脓毒症患者的死亡风险因素：一项基于MIMIC-IV数据库的回顾性队列研究
Ren Fail. 2024 Dec;46(2):2436106. doi: 10.1080/0886022X.2024.2436106. Epub 2024 Dec 4.
3

本文引用的文献

1
Endocan is a reliable biomarker during continuous renal replacement therapy.内皮抑素是连续性肾脏替代治疗期间一种可靠的生物标志物。
Crit Care. 2019 Sep 3;23(1):296. doi: 10.1186/s13054-019-2585-4.
2
Renal clearance of heparin-binding protein and elimination during renal replacement therapy: Studies in ICU patients and healthy volunteers.肝素结合蛋白在 ICU 患者和健康志愿者中的肾清除率和肾替代治疗期间的消除率：研究。
PLoS One. 2019 Aug 29;14(8):e0221813. doi: 10.1371/journal.pone.0221813. eCollection 2019.
3
What Have We Learned about the Use of Cytosorb Adsorption Columns?
Sepsis Biomarkers: Advancements and Clinical Applications-A Narrative Review.
脓毒症生物标志物：进展与临床应用——叙述性综述。
Int J Mol Sci. 2024 Aug 19;25(16):9010. doi: 10.3390/ijms25169010.
4
Heparin-binding protein as a biomarker for the diagnosis of sepsis in the intensive care unit: a retrospective cross-sectional study in China.肝素结合蛋白作为重症监护病房脓毒症诊断的生物标志物：中国的回顾性横断面研究。
BMJ Open. 2024 Jun 10;14(6):e078687. doi: 10.1136/bmjopen-2023-078687.
5
Reply to "Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients".对《脓毒症休克患者中S100A8/A9升高与左心室功能障碍之间潜在混杂因素》的回复
Crit Care. 2024 Jan 2;28(1):9. doi: 10.1186/s13054-023-04789-9.
6
Potential confounders in linking elevated S100A8/A9 to left ventricular dysfunction in septic shock patients.脓毒症休克患者中S100A8/A9升高与左心室功能障碍之间潜在的混杂因素。
Crit Care. 2023 Dec 6;27(1):480. doi: 10.1186/s13054-023-04769-z.
7
Procalcitonin decrease predicts survival and recovery from dialysis at 28 days in patients with sepsis-induced acute kidney injury receiving continuous renal replacement therapy.降钙素原降低预测接受连续肾脏替代治疗的脓毒症诱导的急性肾损伤患者在 28 天时的生存和透析恢复。
PLoS One. 2022 Dec 27;17(12):e0279561. doi: 10.1371/journal.pone.0279561. eCollection 2022.
8
PSP is a promising biomarker of sepsis; however, potential elimination by RRT must be considered.嗜酸性粒细胞阳离子蛋白是脓毒症一种很有前景的生物标志物；然而，必须考虑到其可能会被肾脏替代治疗清除。
Crit Care. 2022 Nov 7;26(1):342. doi: 10.1186/s13054-022-04214-7.
9
Biomarkers Predicting Tissue Pharmacokinetics of Antimicrobials in Sepsis: A Review.生物标志物预测脓毒症中抗菌药物的组织药代动力学：综述。
Clin Pharmacokinet. 2022 May;61(5):593-617. doi: 10.1007/s40262-021-01102-1. Epub 2022 Feb 25.
10
Effects of intermittent hemodialysis on plasmatic levels of endocan.间歇性血液透析对内皮糖蛋白血浆水平的影响。
Crit Care. 2021 Nov 29;25(1):412. doi: 10.1186/s13054-021-03829-6.
我们从细胞吸附柱的使用中学到了什么？
Blood Purif. 2019;48(3):196-202. doi: 10.1159/000500013. Epub 2019 Apr 30.
4
An evaluation of clinical inflammatory and coagulation markers in patients with sepsis: a pilot study.脓毒症患者临床炎症和凝血标志物的评估：一项初步研究。
Acute Med Surg. 2019 Mar 1;6(2):158-164. doi: 10.1002/ams2.397. eCollection 2019 Apr.
5
Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.内消蛋白、脓毒症、肺炎和急性呼吸窘迫综合征。
Crit Care. 2018 Oct 26;22(1):280. doi: 10.1186/s13054-018-2222-7.
6
Changes of Serum Procalcitonin (PCT), C-Reactive Protein (CRP), Interleukin-17 (IL-17), Interleukin-6 (IL-6), High Mobility Group Protein-B1 (HMGB1) and D-Dimer in Patients with Severe Acute Pancreatitis Treated with Continuous Renal Replacement Therapy (CRRT) and Its Clinical Significance.连续性肾脏替代治疗（CRRT）对重症急性胰腺炎患者血清降钙素原（PCT）、C 反应蛋白（CRP）、白细胞介素-17（IL-17）、白细胞介素-6（IL-6）、高迁移率族蛋白 B1（HMGB1）和 D-二聚体的影响及其临床意义。
Med Sci Monit. 2018 Aug 23;24:5881-5886. doi: 10.12659/MSM.910099.
7
Membranes and Sorbents.膜与吸附剂。
Contrib Nephrol. 2018;194:70-79. doi: 10.1159/000485603. Epub 2018 Mar 29.
8
Heparin-binding protein: a key player in the pathophysiology of organ dysfunction in sepsis.肝素结合蛋白：脓毒症器官功能障碍病理生理学的关键因素。
J Intern Med. 2017 Jun;281(6):562-574. doi: 10.1111/joim.12604. Epub 2017 Mar 28.
9
Pentraxin 3: an immune modulator of infection and useful marker for disease severity assessment in sepsis.五聚体蛋白3：感染的免疫调节剂及脓毒症疾病严重程度评估的有用标志物
Expert Rev Clin Immunol. 2016;12(5):501-7. doi: 10.1586/1744666X.2016.1166957. Epub 2016 Mar 31.
10
Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities.危重症患者急性肾损伤的潜在新型介质：持续静静脉血液滤过处理及抗凝方式的影响
BMC Nephrol. 2015 Oct 30;16:178. doi: 10.1186/s12882-015-0167-5.